Shandong Boan Biotechnology Co., Ltd. logo

Shandong Boan Biotechnology Co., Ltd.

6955.HK

HKSEHealthcareBiotechnology

Latest quote

HK$4.025

−HK$0.285 · -6.61%

Aug 24, 4:08 PM HKT

6955.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company, which engages in therapeutic antibody development, manufacturing and commercialization. It operates through the Mainland China and Other countries geographical segments. It focuses on key therapeutic areas including oncology, metabolism, autoimmunity, and ophthalmology. The company was founded on December 30, 2013 and is headquartered in Yantai, China.

Industry
Biotechnology
Sector
Healthcare
Headquarters
CN
CEO
Jiang Hua
Listed since
Dec 29, 2022
Employees
696

Market position

Day range

Current HK$4.025

52-week range

Current HK$4.025

Open
HK$4.23
Previous close
HK$4.31
Volume
5.51M
0.92× average
Average volume
6M
Average daily volume
Market cap
2.5B HKD
Beta
0.05
Market reference 1
50-day average
HK$4.7888
-15.95% below average
200-day average
HK$7.0813
-43.16% below average

Earnings

Latest EPS result
0.04

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.170.02-0.14-0.29Q3 '23Q3 '24Q3 '25
Q3 2023, reported Aug 27, 2023: actual -0.249, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 27, 2024: actual 0.129, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 27, 2025: actual 0.044, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates448.34M387.25M326.15M265.06MQ3 '23Q3 '24Q3 '25
Q3 2023, reported Aug 27, 2023: actual 282.3M HKD, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 27, 2024: actual 389.96M HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Aug 27, 2025: actual 431.1M HKD, estimate —, surprise —, Comparison unavailable.

6955.HK peers

ETFs holding 6955.HK

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 6955.HK

research.disclaimer